In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The test, developed by a team at the University of Southampton, uses AI to analyse blood samples for tiny fragments of ...

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

Research suggests the test, known as miONCO-Dx, can detect 12 cancers at an early stage with 99% accuracy. However, a larger ...